EUVIMEDEUVIMED entdecken
Crossref

CJ 2 : A Novel Potent Platinum(IV) Prodrug Enhances Chemo-Immunotherapy by Facilitating PD-L1 Degradation in the Cytoplasm and Cytomembrane

Renming Fan, Aohua Deng, Bing Qi, Shuo Zhang, Ruoxi Sang, Lanxin Luo, Jiakui Gou, Yongqing Liu, Ruizhuo Lin, Minggao Zhao, Yang Liu iD, Le Yang und 2 weitere

Journal of Medicinal Chemistry · 2023

DOI: 10.1021/acs.jmedchem.2c01719 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Renming Fan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Research & Development Institute of Northwestern Polytechnical University, Shenzhen, Guangdong518057, P. R. China. Hauptthemen laut MEDLINE: Drug-Related Side Effects and Adverse Reactions, Neoplasms, Prodrugs. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Ministry of Education of the People's Republic of China, Science and Technology Foundation of Shenzhen City, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Platinum drugs as primary chemotherapy drugs have been applied to various cancer patients. However, their therapeutic applicability is limited due to the adverse effects and immunosuppression. To minimize the side effects and boost the immune response, we designed and synthesized platinum(IV) prodrugs that introduced BRD4 inhibitor JQ-1. Among them, CJ2 had the most potent therapeutic activity and less toxicity. With the introduction of ligand JQ-1, CJ2-reduced PD-L1 protein was found in the cytoplasm and cytomembrane for the first time. By interfering with the PD-L1 synthesis, CJ2 could arouse the immune system and promote CD8+ T cell infiltration. Meanwhile, CJ2 could accelerate PD-L1 degradation in the cytoplasm to block DNA damage repair. In vivo, CJ2 markedly suppressed tumor growth by reversing the immunosuppression microenvironment and enhancing DNA damage. These findings provide an effective approach to improve the selectivity and activity of the platinum drugs with elevated immune response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug-Related Side Effects and Adverse ReactionsNeoplasmsProdrugsHumansB7-H1 AntigenCell Cycle ProteinsCell Line, TumorCytoplasmImmunotherapyNuclear ProteinsPlatinumTranscription FactorsTumor MicroenvironmentBromodomain Containing ProteinsOrganoplatinum Compounds

Substanzen

B7-H1 AntigenCell Cycle ProteinsNuclear ProteinsPlatinumProdrugsTranscription FactorsBRD4 protein, humanBromodomain Containing ProteinsCJ(2)Organoplatinum Compounds

Autor:innen und Institutionen

  • Research & Development Institute of Northwestern Polytechnical University, Shenzhen, Guangdong518057, P. R. China.
  • Xi'an Key Laboratory of Stem Cell and Regenerative Medicine, Institute of Medical Research, Northwestern Polytechnical University, Xi'an, Shaanxi710072, P. R. China.
  • Institute of Oncology, The Second Affiliated Hospital, Xi'an Medical University, Xi'an, Shaanxi710038, P.R. China.
  • Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang110016, P. R. China.
  • Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Air Force Military Medical University, Xi'an, 710038Shaanxi, P. R. China.

ORCID-Profile: Yang Liu, Maosheng Cheng, Gaofei Wei

Förderung

  • Ministry of Education of the People's Republic of China
  • Science and Technology Foundation of Shenzhen City
  • National Natural Science Foundation of China
  • Innovation Capability Support Program of Shaanxi

Zitieren

APA

Fan, R., Deng, A., Qi, B., Zhang, S., Sang, R., Luo, L., Gou, J., Liu, Y., Lin, R., Zhao, M., Liu, Y., Yang, L., Cheng, M., & Wei, G. (2023). CJ 2 : A Novel Potent Platinum(IV) Prodrug Enhances Chemo-Immunotherapy by Facilitating PD-L1 Degradation in the Cytoplasm and Cytomembrane. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.2c01719

Vancouver

Fan R, Deng A, Qi B, Zhang S, Sang R, Luo L, et al. CJ 2 : A Novel Potent Platinum(IV) Prodrug Enhances Chemo-Immunotherapy by Facilitating PD-L1 Degradation in the Cytoplasm and Cytomembrane. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.2c01719

BibTeX
@article{Fan2023,
  author = {Fan, Renming and Deng, Aohua and Qi, Bing and Zhang, Shuo and Sang, Ruoxi and Luo, Lanxin and Gou, Jiakui and Liu, Yongqing and Lin, Ruizhuo and Zhao, Minggao and Liu, Yang and Yang, Le and Cheng, Maosheng and Wei, Gaofei},
  title = {CJ 2 : A Novel Potent Platinum(IV) Prodrug Enhances Chemo-Immunotherapy by Facilitating PD-L1 Degradation in the Cytoplasm and Cytomembrane},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  doi = {10.1021/acs.jmedchem.2c01719}
}
Kostenlos starten →